Influence of plasma-protein binding on analgesic effect of methadone in rats with spontaneous withdrawal

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 3, 1996, Pages 281-284

  Garrido, M J ^a   Jiminez, R ^a   Gomez, E ^a   Calvo, R ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MORPHINE; OROSOMUCOID; PLASMA PROTEIN;

ABSTINENCE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PLASMA PROTEIN BINDING; RAT; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

EID: 0029992791     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05917.x     Document Type: Article

References (18)

1. 1-glycoprotein. Clin Pharmacol. Ther. 32: 652-658
2. Badawy, A. A.-B., Evans, C. M., Evans, M (1982) Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br. J. Pharmacol. 75: 485-491
3. Bell, J., Seres, V., Bowron, P., Lewis, J., Batey, R. (1988) The use of serum methadone levels in patients receiving methadone maintenance. Clin. Pharmacol. Ther. 43: 623-629
4. Bhargava, H. N., Villar, V. M., Rahmani, N. H., Larsen, A. K. (1992) Studies on the possible role of pharmacokinetics in the development of tolerance to morphine in the rat. Gen. Pharmacol. 23: 1199-1204
5. Bläsig, J., Herz, A., Reinhold, K., Zieglgänsberger, S. (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipited withdrawal syndrome in rats. Psychopharmacology 33: 19-38
6. D'Amour, F. E., Smith, D. L. (1941) A method for determining loss of pain sensation. J. Pharmacoa. Exp. Ther. 72: 74-79
7. 2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine. Eur. J. Pharmacol. 114: 365-374
8. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence. Psychopharmacology 92: 320-323
9. Gómez, E., Martínez-Jordá, R., Suárez, E., Garrido, M. J., Calvo, R. (1995) Altered methadone analgesia due to changes in plasma protein binding: role of the route of administration. Gen. Pharmacol. 26: 1273-1276
10. Liu, S. I., Wang, R. I. M. (1985) Effects of acute and chronic morphine treatment on methadone analgesia and metabolism. Eur. J. Pharmacol. 109: 55-63
11. Loimer, N., Schmid, R. (1992) The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend. 30: 241-246
12. March, C., Blanke, R. V. (1985) Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 ultrafiltration system Ther. Drug Monitor. 7. 115-120
13. Routledge, P. A. (1986) The plasma protein binding of basic drugs. Br. J. Clin Pharmacol. 22: 499-506
14. Swann, A. C., Elsworth, J. D., Charney, D. S., Jablonsn, D. M., Roth, R. H., Redmond, D. E., Maas, J. W. (1983) Brain catecholamme metabolites and behaviour in morphine withdrawal Eur J. Pharmacol. 86: 167-175
15. 1-glycoprotein assay. Ann. Clin. Biochem. 17: 140-143
16. Torres, I., Gómez, E., García, E., Suárez, E., Rodríguez-Sasiaín. J. M., Calvo, R. (1992) Influence of changes in protein binding on the central activity of antidepressants. J. Pharm Pharmacol. 44: 531-533
17. 2-adrenoceptor and μ opioid receptor densities during morphine dependence and spontaneous withdrawal in rats. Naunyn Schmiedebergs Arch. Pharmacol. 336: 530-537
18. Wolff, K., Hay, A. W. M., Raistrick, D., Calvert, R. (1993) Steady-state pharmacokinetics of methadone in opioid addicts. Eur. J. Clin. Pharmacol. 44: 189-194